Customize your JAMA Network experience by selecting one or more topics from the list below.
Objective To test how genomic loci identified in genome-wide association studies influence the development of obesity.
Design A 38-year prospective longitudinal study of a representative birth cohort.
Setting The Dunedin Multidisciplinary Health and Development Study, Dunedin, New Zealand.
Participants One thousand thirty-seven male and female study members.
Main Exposures We assessed genetic risk with a multilocus genetic risk score. The genetic risk score was composed of single-nucleotide polymorphisms identified in genome-wide association studies of obesity-related phenotypes. We assessed family history from parent body mass index data collected when study members were 11 years of age.
Main Outcome Measures Body mass index growth curves, developmental phenotypes of obesity, and adult obesity outcomes were defined from anthropometric assessments at birth and at 12 subsequent in-person interviews through 38 years of age.
Results Individuals with higher genetic risk scores were more likely to be chronically obese in adulthood. Genetic risk first manifested as rapid growth during early childhood. Genetic risk was unrelated to birth weight. After birth, children at higher genetic risk gained weight more rapidly and reached adiposity rebound earlier and at a higher body mass index. In turn, these developmental phenotypes predicted adult obesity, mediating about half the genetic effect on adult obesity risk. Genetic associations with growth and obesity risk were independent of family history, indicating that the genetic risk score could provide novel information to clinicians.
Conclusions Genetic variation linked with obesity risk operates, in part, through accelerating growth in the early childhood years after birth. Etiological research and prevention strategies should target early childhood to address the obesity epidemic.
Obesity is known to be heritable, and genome-wide association studies (GWASs) have begun to uncover the molecular roots of this heritability by identifying multiple single-nucleotide polymorphisms (SNPs) associated with a higher adult body mass index (BMI; calculated as weight in kilograms divided by height in meters squared).1 The next step is to understand how these SNPs influence the development of obesity. Individual differences in obesity risk emerge during gestation and are further established during infancy and childhood through accelerated growth trajectories.2,3 Therefore, examination of developmental phenotypes in relation to genetic risk represents a promising approach to understand the pathogenesis of obesity.4-6 In this study, we asked how SNPs with replicated GWAS evidence for association with adult BMI relate to growth across the first 4 decades of life and to adult obesity in a birth cohort followed up prospectively from birth through 38 years of age.
The SNPs identified in GWASs contribute small increments to obesity risk.7 Aggregating GWAS-identified SNPs to produce a genome-wide index (a genetic risk score [GRS]) yields a quantitative measure of inherited predisposition toward a trait, such as BMI.8 This approach has shown promise in the study of complex diseases, such as diabetes mellitus and heart disease.9,10 In this study, we used a multilocus genome risk score to test how a genetic predisposition to higher adult BMI might also relate to developmental phenotypes of growth during proposed critical periods in the development of obesity. The following 3 developmental phenotypes are of interest: growth during gestation, postnatal growth, and the adiposity rebound. All correlate with adult BMI and are thought to program risk for adult obesity.11-13 Therefore, we tested the hypothesis that polygenic risk for adult obesity is mediated by these developmental phenotypes of rapid early growth (Figure 1). Understanding when in development genetic risk for obesity manifests can help to refine research and intervention targets.
Figure 1. Developmental phenotypes of rapid early growth hypothesized to mediate polygenic risk for obesity. The genetic epidemiology of obesity indicates that a large number of common polymorphisms each contribute small, additive increments to risk for obesity.14,15 The combined influence of these polymorphisms can be summarized in a polygenic risk profile.8 The developmental epidemiology of obesity highlights the following 3 developmental phenotypes of rapid early growth that predispose children to become obese in later life: (1) growth during gestation, (2) postnatal growth, and (3) adiposity rebound.11,12 We tested the hypothesis that these developmental phenotypes would mediate polygenic risk for adult obesity. BMI indicates body mass index.
If genetic risk is mediated through early growth, knowledge of how measured genetic risk compares with parental BMI in predicting children's growth and obesity risk is important. We thus tested whether obesity risk information contained in the GRS was independent of obesity risk information contained in the BMIs of the children's parents. That is, does the GRS contain novel information about children's risk for obesity beyond their family history?
Participants are members of the Dunedin Multidisciplinary Health and Development Study, a longitudinal investigation of health and behavior in a complete birth cohort. Study members (1037 members; 91% of eligible births; 52% male) were all individuals born between April 1972 and March 1973 in Dunedin, New Zealand, who were eligible for the longitudinal study based on residence in the province and who participated in the first follow-up assessment at 3 years of age. The cohort represents the full range of socioeconomic status in the general population of New Zealand's South Island and is primarily white. Assessments were performed at birth and at ages 3, 5, 7, 9, 11, 13, 15, 18, 21, 26, 32, and, most recently, 38 years, with greater than 95% retention. At each assessment, study members are brought to the Dunedin research unit for a full day of interviews and examinations. The Otago Ethics Committee approved each phase of the study. The study protocol was approved by the institutional ethical review boards of the participating universities. Informed consent was obtained from all study members.
We derived a 32-SNP GRS from published GWASs of BMI, obesity, weight, and waist circumference in populations of European descent. The construction of the GRS is described in the eMethods. We validated our GRS as a measure of obesity risk in data from the Atherosclerosis Risk in Communities (ARIC) sample.16 ARIC cohort members of European descent who had higher GRSs were larger as measured by BMI, weight, and waist circumference (r > 0.10 [P < 1 × 10−20]) and were more likely to be obese (relative risk, 1.73 [95% CI, 1.51-1.97] for individuals in the highest vs the lowest quintile of the GRS distribution).
We genotyped the 32 GRS SNPs in the Dunedin Study cohort with a commercially available array (BeadPlex Array; Illumina, Inc) using DNA extracted from whole blood (93% of the sample) or buccal swabs (7% of the sample). Of the 32 GRS SNPs, 29 were called successfully in more than 95% of the cohort, and we constructed the final score from these SNPs (eTable 1). Comparison of the 29-SNP GRS with the original 32-SNP GRS in the ARIC sample revealed no differences in score distribution or effect sizes. Dunedin Study members carried 15 to 36 risk alleles (mean [SD], 26.04 [3.32]). After weighting, GRS values ranged from 13.71 to 35.04 (mean [SD], 24.71 [3.59]) (eFigure 1). The GRS was standardized to have a mean of 0 and an SD of 1 for analyses.
Parental BMI was available for 97.82% of the cohort. Parental BMIs were computed from self-reports of height and weight when children were 11 years of age. To measure familial predisposition to obesity, parental BMIs were standardized within sex, and the standardized scores were averaged to create a single family history score.
Individuals' height and weight were measured at ages 3, 5, 7, 9, 11, 13, 15, 18, 21, 26, 32, and 38 years. Height was measured to the nearest millimeter using a portable stadiometer (Harpenden; Holtain, Ltd). Weight was measured to the nearest 0.1 kg at ages 3, 5, 7, 9, 11, 13, 15, 18, 21, 26, 32, and 36 years using calibrated scales. Individuals were weighed in light clothing. Obesity was defined at 15 years of age using US Centers for Disease Control and Prevention cutoff points (BMI ≥ 24.64 for boys; BMI ≥ 25.46 for girls), which show predictive validity for obesity and coronary heart disease in young adulthood that is similar to the International Obesity Task Force cutoff points.17 Obesity was defined at ages 18 to 38 years as a BMI of 30 or greater. Individuals who met obesity criteria for at least 50% of 6 measurements from ages 15 to 38 years were classified as chronically obese.18
At ages 7 and 9 years, tricep and subscapular skinfold thicknesses were measured by trained anthropometrists. At ages 26, 32, and 38 years, waist girth was measured by averaging 2 measurements of the perimeter at the level of the noticeable waist narrowing. At ages 32 and 38 years, fat mass was measured using a body composition analyzer (BC 418; Tanita) to assess bioelectrical impedence.19
Rate of early-childhood weight gain was assessed as the difference between weight at birth (from hospital records) and weight at 3 years of age. Adiposity rebound was calculated as the nadir of each individual's childhood BMI curve fitted across ages 3 through 13 years. We used multilevel longitudinal modeling to fit individual growth curves.20 Models included linear and quadratic slope terms and were adjusted for sex. Children in our sample experienced adiposity rebound at about 6 years of age (mean [SD] age, 6.11 [1.10] years) at a BMI of approximately 16 (mean [SD], 15.57 [1.00]).
We analyzed life-course growth using a multilevel longitudinal growth model20 fitted to BMI measurements at ages 3, 5, 7, 9, 11, 13, 15, 18, 21, 26, 32, and 38 years. We set the intercept at 13 years of age. We modeled separate linear and quadratic slopes for growth during childhood (ages 3-13 years) and adulthood (ages 13-38 years). The intercept captured the sample mean BMI at 13 years of age (β = 19.97). Slope coefficients captured annual change/acceleration in BMI. Linear slope terms captured change in BMI across childhood (β = 1.19) and adulthood (β = 0.51). Quadratic slope terms captured acceleration of change, that is, the concavity of the trajectory in childhood (β = 0.08) and the convexity of the trajectory in adulthood (β = −0.01). All model terms were statistically significant (P < .001).
We tested genetic influence on growth by modeling the intercept and linear slope terms of the life-course growth curve as functions of the GRS and covariates. The GRS coefficients measured the effect of a 1-SD increase in genetic risk on BMI at 13 years of age (intercept) and on the linear change per year in BMI from ages 3 through 13 years (childhood slope) and ages 13 through 38 years (adulthood slope).
We tested genetic associations with cross-sectional measurements of BMI and with other quantitative traits using linear regression models. The GRS coefficients were standardized to effect-size correlations (Pearson r) for ease of interpretation. We tested genetic associations with obesity risk using Poisson regression models. The GRS coefficients were exponentiated to compute relative risks. We tested mediation of genetic risk for obesity through developmental phenotypes of early growth using the structural equation described by MacKinnon and Dwyer.21 Mediation analyses decomposed GRS-obesity associations into direct (unmediated) and indirect (mediated through a developmental phenotype) components. Statistical tests of mediation were conducted using methods described by Preacher and colleagues.22-24
All models were adjusted for sex and constituted the 98% (n = 856) of Dunedin Study members of European descent with available BMI, family history, and genotype data. We used SAS statistical software (version 9.2)25 for growth modeling and mediation analyses and STATA (version 11.0)26 for other analyses.
Children with higher GRSs had higher BMIs at every age assessed, from ages 3 through 38 years (Table 1). In the life-course growth model, higher GRSs predicted higher mean levels of BMI (intercept β = 0.38 [P < .001]), faster growth in childhood (β = 0.03 [P < .001]), and faster growth in adulthood (β = 0.02 [P = .02]). Figure 2 shows life-course growth curves for children with high, low, and average GRSs.
Figure 2. Life-course growth curves for children with high, low, and average genetic risk scores (GRSs). Individuals with higher-obesity GRSs were larger and grew more rapidly as children and adults. The solid line represents the population mean trajectory (average genetic risk). Dashed lines are for subgroups within 1 SD of the GRS (high and low genetic risk). Trajectories were derived from the life-course growth model (intercept fitted at 13 years of age; linear and quadratic slopes fitted during ages 3-13 years and 13-38 years), including intercept and linear slope effects for the GRS. Analyses included 856 individuals of European descent. Body mass index is calculated as weight in kilograms divided by height in meters squared.
To rule out the possibility that variation at the FTO locus (GenBank NC_007316.4) accounted for our observed GRS-growth associations, we repeated the analysis, adjusting slope and intercept estimates for the FTO SNP rs9939609. This SNP is the best-replicated GWAS result for BMI,27 has been shown to influence growth,6,28 and carried the largest weight of any SNP in our GRS. Associations of GRS and growth were unchanged by adjustment for rs9939609. Independent of their rs9939609 genotype, children with higher GRSs were larger across 4 decades of follow-up (intercept β = 0.40 [P < .001]) and grew faster during childhood and during adulthood (childhood linear slope β = 0.03 [P = .003]; adult linear slope β = 0.02 [P = .01]).
To rule out the possibility that GRS-growth associations reflected associations with height or muscle mass and not with adiposity, we tested associations between the GRS and childhood skinfold thicknesses and adult waist-girth and fat-mass measurements. These measurements are less susceptible to inflation as a result of body size and are considered to be more direct measures of body fat.19 The GRS correlations with these alternative measures of adiposity were statistically significant and were similar to GRS correlations with BMI (Table 1).
As teenagers (ages 15-18 years), 5.5% of Dunedin Study children had BMIs in the obese range; in their third decade of life (ages 21-26 years), 11.2% met criteria for obesity; and in their fourth decade of life (ages 32-38 years), 22.3% met criteria for obesity, consistent with the nationwide prevalence among New Zealanders of European descent (http://socialreport.msd.govt.nz/health/obesity.html). We classified 8.4% of the sample as chronically obese. Figure 3 shows obesity prevalences for children at low (below average) and high (above average) genetic risk. Children at high genetic risk were 1.61 to 2.41 times more likely to be obese in their second, third, and fourth decades of life and were 1.90 times more likely to be chronically obese across more than 3 assessments compared with children at low genetic risk.
Figure 3. Obesity prevalence among low and high genetic risk cohort members in their second, third, and fourth decades of life and chronically across ages 15 to 38 years. Individuals with higher genetic risk scores (GRSs) were more likely to be obese across 2 decades of adult follow-up. Error bars and numbers in parentheses reflect 95% CIs. The GRS was dichotomized at the sample mean to create low and high genetic risk categories. Relative risks (RRs) (95% CIs) are reported from Poisson regression models adjusted for sex that included the 856 individuals of European descent in the analysis sample.
To determine whether genetic risk for obesity was mediated by rapid early growth, we investigated relationships among the children's GRSs, their growth during gestation and childhood, and their obesity outcomes across ages 15 to 38 years.
The first developmental period theorized to entrain adult obesity risk is gestation. However, the GRS was not associated with fetal growth as indexed by birth weight (r = 0.00 [P > .90]) (Table 1). Nevertheless, by 3 years of age, children at higher genetic risk had higher BMIs relative to their peers (r = 0.08 [P = .04]), raising the question whether growth during a second developmental period, from birth to 3 years of age, mediated the genetic risk for obesity. Children at higher genetic risk gained more weight from birth to 3 years of age (r = 0.09 [P = .01]) (Table 1). Consistent with previous research,29,30 children with more rapid weight gain during these years were more likely to become obese (Table 2). Decomposition of GRS-obesity associations into direct and indirect effects indicated that weight gain from birth to 3 years of age mediated statistically significant portions of genetic risk for obesity in the teenage years and for chronic obesity, but not for obesity, in the third or fourth decade of life individually (Table 2).
Adiposity rebound, when children begin to gain body fat after losing it during early childhood, is a third period in development theorized to entrain adult obesity. For children at higher genetic risk, adiposity rebound occurred earlier in development and at higher BMI (r = −0.13 for age and r = 0.17 for BMI [P < .001 for both]) (Table 1). Consistent with previous research,11,31 children with earlier adiposity rebound and higher BMI at adiposity rebound were more likely to become obese (Table 2). Decomposition of GRS-obesity associations into direct and indirect effects revealed that adiposity rebound mediated large and statistically significant portions of genetic risk for obesity in the second, third, and fourth decades of life and for chronic obesity (Table 2).
Higher genetic risk predicted faster growth and increased risk for obesity in children with normal-weight and overweight parents (Figure 4). That is, the GRS contributed independent and additive information to the prediction of children's growth and their risk for obesity in adulthood beyond the family history information (eTable 2).
Figure 4. Influence of genetic risk and family history on growth and obesity risk. The genetic risk score (GRS) contained information about children's growth and their obesity risk that was not available in their family histories. Genetic risk and family history made independent and additive contributions to life-course growth predictions and to adult obesity risk in 856 individuals of European descent. A, Life-course growth curves show that genetic risk and family history made additive contributions to growth predictions. B, Bar graph shows that genetic risk and family history made additive contributions to children's risk of becoming obese. Error bars reflect 95% CIs. Statistical analyses illustrating the independence of the GRS and family history in predicting growth and obesity risk are presented in eTable 2. Body mass index is calculated as weight in kilograms divided by height in meters squared.
We conducted a developmental genetic investigation into the etiology of obesity in a prospective birth cohort study with 4 decades of follow-up. We measured polygenic risk for obesity using a multilocus GRS derived from GWASs of obesity-related phenotypes. Our analyses revealed that polygenic risk for obesity was partly mediated by rapid growth in the early childhood years after birth. This finding supported our hypothesis that developmental phenotypes were critical in linking a genetic predisposition to adult obesity. Furthermore, risk for obesity measured by the genetic risk score was independent of risk information available in parental BMI.
These findings have implications for clinical practice and for developmental and epidemiologic research. First, the results suggest promise for using genetic information in obesity risk assessments. Parental BMI has been proposed as a screening measure to target obesity prevention in children on the basis of effect-size correlations only slightly larger than those we report for our GRS.32 New developments in genome science, including next-generation sequencing, may uncover new variants that further improve the performance of SNP-based risk assessments.33-35 Moreover, the GRS contained information about children's future obesity risk that could not be derived from measurements of parents, suggesting that positive family history may not always be an appropriate prerequisite for genetic testing. Second, our findings illustrate how polygenic influences on development can be investigated using the GRS. Prospective cohort studies containing repeated measures are necessary to elucidate developmental processes leading to complex diseases.36 However, to date, small single-locus effect sizes have made it challenging to incorporate genetic information into ongoing cohort studies. To address the challenge of small effects, we used a multilocus profile. The resulting GRS enables measurement of a larger, genome-wide effect size and reduces the number of hypothesis tests to 1, making follow-up of GWAS findings tractable in cohort studies that are needed to study development. Third, the longitudinal results illustrate that investigations of obesity as an outcome to developmental processes can inform public health initiatives and research priorities by identifying specific phases in development when genetic risk becomes manifest and thus might be amenable to intervention. Childhood growth in general—and, in particular, growth during the period between birth and the adiposity rebound—should be a focus for future research to understand genetic contributions to the development of obesity.
We acknowledge 3 limitations. First, we derived our GRS from GWASs of Europeans and conducted our study in individuals of European descent; these results may not generalize to other populations.37 Second, our family histories included only parents. More complete family histories might have greater overlap with the GRS. Third, we were unable to characterize growth trajectories during the earliest stages of life; regular follow-up of the cohort did not begin until 3 years of age. However, results from our analyses of birth weight and of weight gain from birth though 3 years of age were consistent with previous genetic investigations of this interval that did include repeated measurements.5,6,38,39 Moreover, we were able to capture growth from 3 years of age and onward with a high degree of resolution; our study included 12 measurements taken during the subsequent 35 years. In addition to repeated measures of height and weight, our study included more direct measures of adiposity, including childhood measurements of skinfold thicknesses and adult measurements of waist circumference and fat mass, all of which were associated with our GRS in parallel to BMI. Thus, the results present compelling evidence that SNPs identified in GWASs of adult BMI and other obesity-related phenotypes predispose to more rapid growth in childhood, leading to increased risk for obesity in adulthood, and provide information not forthcoming from a simple analysis of family history.
Correspondence: Daniel W. Belsky, PhD, Institute for Genome Sciences and Policy, Duke University, Grey House, Ste 201, Duke University Box 104410, Durham, NC 27708 (email@example.com).
Accepted for Publication: February 2, 2012.
Author Contributions:Study concept and design: Belsky, Moffitt, and Caspi. Acquisition of data: Moffitt, Sugden, Williams, Poulton, and Caspi. Analysis and interpretation of data: Belsky, Moffitt, Houts, Bennett, Biddle, Blumenthal, Evans, Harrington, Sugden, Williams, Poulton, and Caspi. Drafting of the manuscript: Belsky, Moffitt, and Caspi. Critical revision of the manuscript for important intellectual content: Belsky, Moffitt, Houts, Bennett, Biddle, Blumenthal, Evans, Harrington, Sugden, Williams, Poulton, and Caspi. Statistical analysis: Belsky, Houts, and Caspi. Obtained funding: Belsky, Moffitt, Poulton, and Caspi. Administrative, technical, and material support: Moffitt, Harrington, Sugden, Williams, Poulton, and Caspi. Study supervision: Moffitt, Poulton, and Caspi.
Financial Disclosure: None reported.
Funding/Support: This study was supported by grant G0601483 from the UK Medical Research Council, grant AG032282 from the National Institute on Aging, and grant MH077874 from the National Institute of Mental Health. Additional support was provided by the Jacobs Foundation and fellowship 1R36HS020524-01 from the Agency for Healthcare Research and Quality (Dr Belsky). The Dunedin Multidisciplinary Health and Development Research Unit was supported by the New Zealand Health Research Council.
Additional Contributions: We thank the Dunedin Study members, their families, unit research staff, and study founder Phil Silva, PhD.
eMethods. Construction of the obesity genetic risk score (GRS)
eTable 1. Single-nucleotide polymorphisms included in the genetic risk score
eTable 2. Genetic risk score and the family history score have independent effects on growth and obesity risk
eTable 3. Indirect effects of the genetic risk score on adult obesity outcomes mediated by weight gain from birth through 3 years of age and the adiposity rebound
eFigure 1. Distribution of the genetic risk score
This supplementary material has been provided by the authors to give readers additional information about their work.
Belsky DW, Moffitt TE, Houts R, et al. Polygenic Risk, Rapid Childhood Growth, and the Development of ObesityEvidence From a 4-Decade Longitudinal Study. Arch Pediatr Adolesc Med. 2012;166(6):515–521. doi:10.1001/archpediatrics.2012.131
Create a personal account or sign in to: